A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

The first report to compare what pharmaceutical companies are doing to bring antimicrobial resistance under control. By highlighting where good ideas are being implemented, it encourages their wider uptake.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

In the media

Read how the global media covers how pharmaceutical companies respond to market trends and global health issues using the Foundation's research, and translates the complexity of access to medicine for the public.

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

05 Aug 2019

How voluntary licensing agreements are transforming HIV care

Rebecca Root writes for Devex about the impact of voluntary licensing for the HIV medicine dolutegravir (DTG) in low-income countries. 

24 Jun 2019

Drug Companies Are Focusing on the Poor After Decades of Ignoring Them

Writing in The New York Times, Donald G. McNeil Jr. charts the progress made by pharmaceutical companies on access to medicine since the HIV/AIDS cris...

20 May 2019

Industry steps up interest in developing world, fueling doubling of R&D pipeline

The Foundation's 10-year analysis on the pharmaceutical industry and global health is covered by Nick Paul Taylor in this piece for FierceBiotech. Nic...

16 May 2019

Pharma industry improves access to medicines in developing world

Writing for the Financial Times, Clive Cookson covers the Foundation’s latest research report — the first 10-year analysis on how the pharmaceut...

16 May 2019

Pharma is making progress addressing global health, but it’s still a mixed bag

Ed Silverman of STAT news reports on the Foundation's first 10-year progress report on how pharmaceutical companies are responding to calls to improve...

01 Apr 2019

Access to medicines - business as usual?

The Lancet highlights key findings from the 2018 Access to Medicine Index, for example, that while all 20 pharmaceutical companies assessed...

06 Feb 2019

Insights and expectations on Japanese investors and pharmaceutical companies

Bowen Gu, Investor Engagement Manager at the Access to Medicine Foundation talks to Etsuya Hirose, Nakatsuka Kazunori and Ayaka Hirai in this QUICK ES...

20 Nov 2018

Cancer Breakthroughs Are Set to Elude World's Poor, Study Says

Writing for Bloomberg, Naomi Kresge covers the results of the latest Access to Medicine Index: "Giant drugmakers pouring resources into new...

20 Nov 2018

Big pharma failing to develop urgent drugs for poorest countries

Julia Kollewe of the Guardian covers the latest Access to Medicine Index: "most firms focus on infectious diseases such as HIV/Aids, malaria and tuber...

20 Nov 2018

Only a few drug makers are actively targeting medicines needed in poor countries

In this article, Ed Silverman of STAT news covers the results of the 2018 Access to Medicine Index: "A new report finds five large drug makers ar...

20 Nov 2018

GSK tops ranking for making drugs available to poor people

Rebecca Coombes of the British Medical Journal covers the Foundation's latest Access to Medicine Index. The article highlights the five companies carr...

20 Nov 2018

Research burden carried by a handful of drug companies, says report

Jyothi Datta of the Hindu Business Line reports on the results of the 2018 Access to Medicine Index. The article focuses on the handful companies carr...

20 Nov 2018

Pharmariesen könnten mehr tun

Writing for Basler Zeitung, Patrick Griesser covers the results of the Foundation's latest Access to Medicine Index. The article highlights the indust...

20 Nov 2018

GSK retains leading position on access to medicines list

Selina McKee of PharmaTimes reports on the results of the 2018 Access to Medicine Index, with highlights from the leaders and details on what makes th...

20 Nov 2018

Coalities nodig voor betere toegang tot medicijnen

Writing for the NRC, Daan van Lant covers the publication of the 2018 Access to Medicine. The article highlights the industry's engagement in priority...

20 Nov 2018

Who are the best — and worst — among the major pharmas at developing drugs for the poor?

John Carroll of Endpoints News reports on the results of the 2018 Access to Medicine Index, highlighting the leaders in the Index, and noting those co...

Got a question?

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.